Follow
Jingwen Zhang
Jingwen Zhang
Oncology iMed, AstraZeneca
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells
B Li, MA Antonyak, J Zhang, RA Cerione
Oncogene 31 (45), 4740-4749, 2012
3702012
AZD5153: a novel bivalent BET bromodomain inhibitor highly active against hematologic malignancies
GW Rhyasen, MM Hattersley, Y Yao, A Dulak, W Wang, P Petteruti, ...
Molecular cancer therapeutics 15 (11), 2563-2574, 2016
1452016
Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication
ST Rasool, H Tang, J Wu, W Li, MM Mukhtar, J Zhang, Y Mu, HX Xing, ...
Immunology letters 117 (2), 161-167, 2008
1272008
BRD4 facilitates replication stress-induced DNA damage response
J Zhang, AM Dulak, MM Hattersley, BS Willis, J Nikkilä, A Wang, A Lau, ...
Oncogene 37 (28), 3763-3777, 2018
872018
A mechanism for the upregulation of EGF receptor levels in glioblastomas
J Zhang, MA Antonyak, G Singh, RA Cerione
Cell reports 3 (6), 2008-2020, 2013
592013
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors
GW Rhyasen, Y Yao, J Zhang, A Dulak, L Castriotta, K Jacques, W Zhao, ...
PLoS One 13 (7), e0200826, 2018
502018
Generation of stable PDX derived cell lines using conditional reprogramming
A Borodovsky, TJ McQuiston, D Stetson, A Ahmed, D Whitston, J Zhang, ...
Molecular cancer 16, 1-7, 2017
412017
Pharmacological inhibition of PARP6 triggers multipolar spindle formation and elicits therapeutic effects in breast cancer
Z Wang, SE Grosskurth, T Cheung, P Petteruti, J Zhang, X Wang, W Wang, ...
Cancer research 78 (23), 6691-6702, 2018
352018
Identify BRD4 as a facilitator of replication stress response signaling
J Zhang, B Willis, M Hattersley, A Lau, C Reimer, M Zinda, S Fawell, ...
Cancer Research 77 (13_Supplement), 1026-1026, 2017
2017
Abstract B21: Brd4 modulates S-phase checkpoint response and sensitizes ovarian cancer cells to ATR inhibition
J Zhang, H Chen, A Dulak
Clinical Cancer Research 23 (1_Supplement), B21-B21, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–10